Alpha Spike Protein

Lab Reagents

Human IgG antibody Laboratories manufactures the alpha spike protein reagents distributed by Genprice. The Alpha Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Alpha products are available in stock. Specificity: Alpha Category: Spike Group: Protein

Protein information

Rabbit Anti-MERS-CoV Spike protein S2 (726-1296 a.a) IgG, aff pure

MERSS22-A 100 ul
EUR 578.4

Recombinant (E. coli) Hepatitis virus (MHV/Coronavirs) Spike Protein S1 protein control for Western blot

MHVS14-C 100 ul
EUR 343.2

SARS-CoV-2 Spike P681H Antibody (Alpha, Mu Variant)

9359-002mg 0.02 mg
EUR 229.7
Description: In September of 2020 a new lineage of SARS-CoV-2, known as B.1.1.7, was discovered in the United Kingdom. This lineage was found to have developed 14 lineage-specific amino acid replacements and 3 deletions prior to its discovery. The transmission of UK variant (B.1.1.7 lineage) was increased at least 50%. Increased severity and higher death rate were also found in UK variant. UK variant will not affect the effectiveness of COVID19 vaccine. One of the mutations associated with this lineage is a N501Y in the spike protein of the virus. It is believed that this mutation is able to increase the spike protein's affinity for the host ACE2 receptor and it has been associated with increased infectivity and virulence. B.1.1.7 viruses have also been shown to have a P681H in the cleavage site of spike protein. This location is one of the residues that make up the furin cleavage site between S1 and S2 in spike protein.

SARS-CoV-2 Spike P681H Antibody (Alpha, Mu Variant)

9359-01mg 0.1 mg
EUR 594.26
Description: In September of 2020 a new lineage of SARS-CoV-2, known as B.1.1.7, was discovered in the United Kingdom. This lineage was found to have developed 14 lineage-specific amino acid replacements and 3 deletions prior to its discovery. The transmission of UK variant (B.1.1.7 lineage) was increased at least 50%. Increased severity and higher death rate were also found in UK variant. UK variant will not affect the effectiveness of COVID19 vaccine. One of the mutations associated with this lineage is a N501Y in the spike protein of the virus. It is believed that this mutation is able to increase the spike protein's affinity for the host ACE2 receptor and it has been associated with increased infectivity and virulence. B.1.1.7 viruses have also been shown to have a P681H in the cleavage site of spike protein. This location is one of the residues that make up the furin cleavage site between S1 and S2 in spike protein.

SARS Spike Peptide

3219P 0.05 mg
EUR 197.7
Description: (NT) SARS Spike peptide

SARS Spike Peptide

3525P 0.05 mg
EUR 197.7
Description: (CT) SARS Spike peptide

SARS Spike Antibody

24216-100ul 100ul
EUR 468

SARS Spike Antibody

24217-100ul 100ul
EUR 468

SARS Spike Antibody

24218-100ul 100ul
EUR 468

SARS Spike Antibody

24219-100ul 100ul
EUR 468

SARS Spike Antibody

24318-100ul 100ul
EUR 468

SARS Spike Antibody

20-abx137184
  • EUR 1262.40
  • EUR 1846.80
  • EUR 2064.00
  • 100 ug
  • 200 ug
  • 300 µg

SARS Spike Antibody

20-abx137200
  • EUR 1412.40
  • EUR 2264.40
  • EUR 2665.20
  • 100 ug
  • 200 ug
  • 300 µg

Spike Glycoprotein Antibody

20-abx300551
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Acids Matrix Spike

CLPS-MSA 1ML
EUR 120.84

TCLP Volatiles Spike

TCLP-VX 1ML
EUR 106.02

Mouse monoclonal Anti-MERS-CoV Spike protein S2 (726-1296 a.a) IgG, aff pure

MERSS21-M 100 ul
EUR 578.4